Pulmonary Rehabilitation Unit, Morlaix Hospital Centre, EA3878, European University of Occidental Brittany, Morlaix, France
Pulmonary Physiology Unit, EA2438, European University of Occidental Brittany, University Brest Centre, Brest, France.
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.01107-2017. Print 2018 Jan.
The benefit of inspiratory muscle training (IMT) combined with a pulmonary rehabilitation programme (PRP) is uncertain. We aimed to demonstrate that, in severe and very severe chronic obstructive pulmonary disease (COPD) patients, IMT performed during a PRP is associated with an improvement of dyspnoea.In a single-blind randomised controlled trial, 150 severe or very severe COPD patients were allocated to follow PRP+IMT PRP alone. The evaluations were performed at inclusion and after 4 weeks. The primary outcome was the change in dyspnoea using the Multidimensional Dyspnoea Profile questionnaire at the end of a 6-min walk test (6MWT) at 4 weeks. Secondary outcomes were changes in dyspnoea using the Borg (end of the 6MWT) and modified Medical Research Council scales and in functional parameters (maximal inspiratory pressure (), inspiratory capacity, 6MWT and quality of life). All analyses were performed on an intention-to-treat basis.Dyspnoea decreased significantly in both groups; however, the improvement of dyspnoea was not statistically different between the two groups. We only found a statistically significant greater increase of after IMT+PRP than after PRP alone.In this trial including severe or very severe COPD patients, we did not find a significant benefit of IMT during PRP+IMT as compared to PRP alone on dyspnoea, despite a significantly higher improvement of in the IMT group.
吸气肌训练(IMT)联合肺康复方案(PRP)的益处尚不确定。我们旨在证明,在严重和极严重慢性阻塞性肺疾病(COPD)患者中,PRP 期间进行的 IMT 与呼吸困难的改善相关。
在一项单盲随机对照试验中,150 名严重或极严重 COPD 患者被分配接受 PRP+IMT 或 PRP 单独治疗。评估在纳入时和 4 周后进行。主要结局是在 4 周时的 6 分钟步行试验(6MWT)结束时使用多维呼吸困难量表评估呼吸困难的变化。次要结局是在 Borg(6MWT 结束时)和改良的医学研究理事会量表以及功能参数(最大吸气压力()、吸气量、6MWT 和生活质量)中呼吸困难的变化。所有分析均基于意向治疗进行。
两组患者的呼吸困难均显著减轻;然而,两组之间呼吸困难的改善无统计学差异。我们仅发现 IMT+PRP 后 较 PRP 单独治疗后有统计学显著增加。
在这项纳入严重或极严重 COPD 患者的试验中,我们没有发现 PRP+IMT 与 PRP 单独治疗相比,在呼吸困难方面有显著的益处,尽管 IMT 组的 改善有显著统计学差异。